Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

November 30, 2010; 75 (22) Special Article

Quality improvement in neurology: AAN Parkinson disease quality measures

Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology Graphic

E.M. Cheng, S. Tonn, R. Swain-Eng, S.A. Factor, W.J. Weiner, C.T. Bever, For the American Academy of Neurology Parkinson Disease Measure Development Panel
First published November 29, 2010, DOI: https://doi.org/10.1212/WNL.0b013e3181ff96dd
E.M. Cheng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Tonn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Swain-Eng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.A. Factor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W.J. Weiner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C.T. Bever Jr.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Quality improvement in neurology: AAN Parkinson disease quality measures
Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology Graphic
E.M. Cheng, S. Tonn, R. Swain-Eng, S.A. Factor, W.J. Weiner, C.T. Bever, For the American Academy of Neurology Parkinson Disease Measure Development Panel
Neurology Nov 2010, 75 (22) 2021-2027; DOI: 10.1212/WNL.0b013e3181ff96dd

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
2615

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Background: Measuring the quality of health care is a fundamental step toward improving health care and is increasingly used in pay-for-performance initiatives and maintenance of certification requirements. Measure development to date has focused on primary care and common conditions such as diabetes; thus, the number of measures that apply to neurologic care is limited. The American Academy of Neurology (AAN) identified the need for neurologists to develop measures of neurologic care and to establish a process to accomplish this.

Objective: To adapt and test the feasibility of a process for independent development by the AAN of measures for neurologic conditions for national measurement programs.

Methods: A process that has been used nationally for measure development was adapted for use by the AAN. Topics for measure development are chosen based upon national priorities, available evidence base from a systematic literature search, gaps in care, and the potential impact for quality improvement. A panel composed of subject matter and measure development methodology experts oversees the development of the measures. Recommendation statements and their corresponding level of evidence are reviewed and considered for development into draft candidate measures. The candidate measures are refined by the expert panel during a 30-day public comment period and by review by the American Medical Association for Current Procedural Terminology (CPT) II codes. All final AAN measures are approved by the AAN Board of Directors.

Results: Parkinson disease (PD) was chosen for measure development. A review of the medical literature identified 258 relevant recommendation statements. A 28-member panel approved 10 quality measures for PD that included full specifications and CPT II codes.

Conclusion: The AAN has adapted a measure development process that is suitable for national measurement programs and has demonstrated its capability to independently develop quality measures.

Footnotes

  • AAN
    American Academy of Neurology
    ABPN
    American Board of Psychiatry and Neurology
    AMA
    American Medical Association
    CPT II
    Current Procedural Terminology
    PCPI
    Physician Consortium for Performance Improvement
    PD
    Parkinson disease
    PMAG
    Performance Measurement Advisory Group
    PQRI
    Physician Quality Reporting Initiative
    QMR
    Quality Measurement and Reporting Subcommittee

  • Supplemental data at www.neurology.org

  • Parkinson disease measurement set approved by the AAN Parkinson Disease Measure Development Panel on December 11, 2009; by the Quality Measurement and Reporting Subcommittee on December 15, 2009; by the Practice Committee on December 15, 2009; and by the AAN Board of Directors on December 21, 2009.

  • Quality Measurement and Reporting Subcommittee members are listed in appendix e-1 on the Neurology® Web site at www.neurology.org.

  • Received May 24, 2010.
  • Accepted September 10, 2010.
  • Copyright © 2010 by AAN Enterprises, Inc.
View Full Text

Disputes & Debates: Rapid online correspondence

  • Re:Quality improvement in neurology: AAN Parkinson disease quality measures
    • Howard D. Weiss, Chernow Clinical Scholar in Neurology and Director of the Parkinson disease program, Sinai Hospital of Baltimorehowdyweiss@aol.com
    Submitted December 30, 2011
  • Quality improvement in neurology: AAN Parkinson disease quality measures
    • Stephen G. Reich, Neurologist, University of Marylandsreich@som.umaryland.edu
    Submitted March 28, 2011
  • Reply from the author
    • Eric M. Cheng, AAN, 1080 Montreal Avenue, St. Paul, MN 55116quality@aan.com
    Submitted March 28, 2011
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • METHODS
    • DISCUSSION
    • PD MEASURE DEVELOPMENT PANEL
    • DISCLOSURE
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Topics Discussed

  • CME
  • All Clinical Neurology
  • Parkinson's disease/Parkinsonism
  • Patient safety

Alert Me

  • Alert me when eletters are published
Neurology: 96 (9)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise